NO20000184L - Nye purinderivater og medisinsk anvendelse derav - Google Patents
Nye purinderivater og medisinsk anvendelse deravInfo
- Publication number
- NO20000184L NO20000184L NO20000184A NO20000184A NO20000184L NO 20000184 L NO20000184 L NO 20000184L NO 20000184 A NO20000184 A NO 20000184A NO 20000184 A NO20000184 A NO 20000184A NO 20000184 L NO20000184 L NO 20000184L
- Authority
- NO
- Norway
- Prior art keywords
- hydrocarbon group
- purine derivatives
- replaced
- medical use
- directly bonded
- Prior art date
Links
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 title abstract 2
- 125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 3
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 230000002757 inflammatory effect Effects 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000001721 carbon Chemical group 0.000 abstract 1
- -1 carbon halide Chemical class 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003212 purines Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20529097 | 1997-07-15 | ||
| PCT/JP1998/003109 WO1999003858A1 (fr) | 1997-07-15 | 1998-07-10 | Derives purine et leur application medicinale |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000184D0 NO20000184D0 (no) | 2000-01-14 |
| NO20000184L true NO20000184L (no) | 2000-03-14 |
Family
ID=16504531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000184A NO20000184L (no) | 1997-07-15 | 2000-01-14 | Nye purinderivater og medisinsk anvendelse derav |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6310070B1 (fr) |
| EP (1) | EP0999211A4 (fr) |
| KR (1) | KR20010021905A (fr) |
| AU (1) | AU730824B2 (fr) |
| CA (1) | CA2295811A1 (fr) |
| NO (1) | NO20000184L (fr) |
| NZ (1) | NZ502752A (fr) |
| TW (1) | TW480260B (fr) |
| WO (1) | WO1999003858A1 (fr) |
| ZA (1) | ZA986273B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2437840A1 (fr) * | 2001-03-05 | 2002-09-12 | E.I. Du Pont De Nemours | Agents heterocycliques diamide de lutte contre des parasites invertebres |
| US20040102324A1 (en) * | 2002-02-28 | 2004-05-27 | Annis Gary David | Heterocyclic diamide invertebrate pest control agents |
| AU2002363960B2 (en) * | 2001-12-06 | 2008-07-10 | Merck Sharp & Dohme Corp. | Mitotic kinesin inhibitors |
| EP1635846A4 (fr) * | 2003-06-20 | 2009-01-28 | Coley Pharm Gmbh | Antagonistes des recepteurs toll (tlr) pour petites molecules |
| EP1734820A4 (fr) * | 2004-04-16 | 2008-01-23 | Neurogen Corp | Imidazopyrazines, imidazopyridines, et imidazopyrimidines utilisees comme ligands du recepteur crf1 |
| SG11201710695XA (en) | 2015-06-22 | 2018-01-30 | Sumitomo Dainippon Pharma Co Ltd | 1,4-disubstituted imidazole derivative |
| US10898469B2 (en) | 2016-02-26 | 2021-01-26 | Sumitomo Dainippon Pharma Co., Ltd. | Imidazolylamide derivative |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5734053A (en) * | 1992-06-26 | 1998-03-31 | Pfizer Inc | Purinone antianginal agents |
| JPH07316157A (ja) | 1994-03-28 | 1995-12-05 | Japan Energy Corp | ヒポキサンチン誘導体及び炎症性疾患の抑制剤 |
| JP3491711B2 (ja) * | 1994-03-28 | 2004-01-26 | 株式会社ジャパンエナジー | プリン誘導体及び炎症性疾患の抑制剤 |
| FI951367A7 (fi) | 1994-03-28 | 1995-09-29 | Japan Energy Corp | Puriinijohdannaiset ja tulehdustautien tukahduttajat (suppressantit) |
| US5550132A (en) * | 1994-06-22 | 1996-08-27 | University Of North Carolina | Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines |
| US5643893A (en) * | 1994-06-22 | 1997-07-01 | Macronex, Inc. | N-substituted-(Dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| DE19501482A1 (de) * | 1995-01-19 | 1996-07-25 | Bayer Ag | 2,9-disubstituierte Purin-6-one |
| JP3906488B2 (ja) | 1995-02-21 | 2007-04-18 | 味の素株式会社 | プリン誘導体の製造方法 |
| US6124303A (en) * | 1998-09-11 | 2000-09-26 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones |
-
1998
- 1998-07-10 EP EP98931051A patent/EP0999211A4/fr not_active Withdrawn
- 1998-07-10 KR KR1020007000469A patent/KR20010021905A/ko not_active Withdrawn
- 1998-07-10 CA CA002295811A patent/CA2295811A1/fr not_active Abandoned
- 1998-07-10 WO PCT/JP1998/003109 patent/WO1999003858A1/fr not_active Ceased
- 1998-07-10 US US09/462,861 patent/US6310070B1/en not_active Expired - Fee Related
- 1998-07-10 AU AU81287/98A patent/AU730824B2/en not_active Ceased
- 1998-07-10 NZ NZ502752A patent/NZ502752A/xx unknown
- 1998-07-15 ZA ZA9806273A patent/ZA986273B/xx unknown
- 1998-07-15 TW TW087111478A patent/TW480260B/zh not_active IP Right Cessation
-
2000
- 2000-01-14 NO NO20000184A patent/NO20000184L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US6310070B1 (en) | 2001-10-30 |
| EP0999211A1 (fr) | 2000-05-10 |
| CA2295811A1 (fr) | 1999-01-20 |
| WO1999003858A9 (fr) | 2000-02-17 |
| ZA986273B (en) | 1999-07-30 |
| NZ502752A (en) | 2001-01-26 |
| TW480260B (en) | 2002-03-21 |
| AU730824B2 (en) | 2001-03-15 |
| AU8128798A (en) | 1999-02-10 |
| WO1999003858A1 (fr) | 1999-01-28 |
| EP0999211A4 (fr) | 2001-09-19 |
| NO20000184D0 (no) | 2000-01-14 |
| KR20010021905A (ko) | 2001-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU91162I2 (fr) | Aloxi-Palonosétrone et ses dérivés pharmaceutiquement acceptables. | |
| ES476305A1 (es) | Un procedimiento para la preparacion de nuevos derivados aminicos | |
| EA200601235A1 (ru) | Производные тиазола | |
| DE60140456D1 (de) | Aza heterocyclische derivate und ihre therapeutische verwendung | |
| NO20052038L (no) | Ny adeninforbindelse og anvendelse derav | |
| DE69706407D1 (de) | META-SUBSTITUIERTE PHENYLENDERIVATE UND IHRE VERWENDUNG ALS ALPHAvBETA3 INTERGRIN-ANTAGONISTEN ODER INHIBITOREN | |
| NO963506L (no) | 4-Heterocyklyl-substituerte kinazolin-derivater, fremgangsmåte for fremstilling derav og deres anvendelse som anti-kreftmidler | |
| EA200000731A1 (ru) | Альфа-аминоамидные производные, полезные в качестве анальгетических агентов | |
| DK0452873T3 (da) | 1,8-naphthyridin-2-on-derivater | |
| PT628311E (pt) | Derivado de xantina com actividade antidepressiva | |
| DK0625977T3 (da) | Piperazinderivater som 5-1A-antagonister | |
| EP1553084A4 (fr) | Derive piperidine, procede de production, et utilisation | |
| DE69519385D1 (de) | Chinazolinon-arzneimittel sowie deren verwendung | |
| AR068695A2 (es) | Uso de un compuesto de tiazol que comprende un derivado de tiazol para la fabricacion de un medicamento para la prevencion y el tratamiento de en-fermedades causadas por la produccion anormal de citocinas y/o la acele-racion de la adhesion de neutrofilos y/o la produccion anormal de tnf- alfa | |
| NO20000184L (no) | Nye purinderivater og medisinsk anvendelse derav | |
| ATE240306T1 (de) | Benzothiadiazinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| ATE182331T1 (de) | Oxazolidone derivative als monoamine- oxidaseinhibitoren | |
| DE69202120D1 (de) | Harnstoffderivate, ihre Herstellung und ihre Verwendung bei der Therapie. | |
| ES8203354A1 (es) | Un procedimiento para la produccion de nuevos derivados heterociclicos,. | |
| EP1550651A4 (fr) | Derive glycerol | |
| ATE118770T1 (de) | Thiazolidinone und oxazolidenonederivate, ihre herstellung und ihre anwendung als vasodilatatoren. | |
| PT1015449E (pt) | Derivados de (hetero)aril-sulfonamida, sua preparacao e sua utilizacao como inibidores do factor xa | |
| HUP9904594A2 (hu) | Piperazinoszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| DE69720966D1 (de) | Benzo[c]chinolizin derivate,deren herstellung und verwendung als 5-alfa-reduktase inhibitoren | |
| MX9405111A (es) | Nuevos derivados de (1-fenil-1-heterociclil)metanol y(1-fenil-1-heterociclil-metilamina). |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |